Kanagawa University (JAPAN)
Abstract title: Natural Products as Drug Leads
The University of Tokushima (JAPAN)
Abstract title: Toward a New Age of Quantitative Structure-Activity Relationship: Linear Expression by Representative Energy Terms
Ankara University (TURKEY)
Abstract title: QSAR and Molecular Modelling Studies on Chemotherapeutic Active Benzazoles
The University of Tokyo (JAPAN)
Abstract title: Intraoperative Imaging of Tiny Tumor Sites with Rationally Designed Fluorescence Probes
Tokyo University of Science (JAPAN)
Abstract title: Organocatalyst in Total Synthesis
Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CHINA)
Abstract title: Target Identification and Lead Discovery by Using Computational Methods
The University of Tokyo (JAPAN)
Abstract title: Drug Design Based on Integration of Chemical Information and Biological Information
Kyoto University (JAPAN)
Abstract title: Small Molecule Tools for Cell Therapy
National Central University (TAIWAN)
Abstract title: Paclitaxel Derivatives and Its Conjugated Bionanoparticles for Targeting Cancer Cells
WuXi AppTec (CHINA)
Abstract title: Experiences from a CRO Perspective in Leveraging Collaborative Medicinal Chemistry: Evolution of Hits to Optimized Tool Compounds for Novel Target Validation In Vivo
Osaka University (JAPAN)
Abstract title: Development of Nucleic Acid Analogues for Antisense Strategy
Newcastle Cancer Centre, Northern Institute for Cancer Research (UK)
Abstract title: Modulation of DNA Damage-Response Pathways in Cancer Therapy
Siena Biotech S.p.A. (ITALY)
Abstract title: Targeting tumour stem cells via the Hedgehog pathway: The discovery of potent Smoothened receptor antagonists for cancer.
Prof. Karl-Heinz Altmann
Swiss Federal Institute of Technology (ETH) (SWITZERLAND)
Abstract title: Natural Products as Leads for Anticancer Drug Discovery
CSIRO (AUSTRALIA)
Abstract title: Design of Modulators of Stem Cell Fate
Janssen-Cilag / Tibotec (FRANCE)
Abstract title: Diarylquinoline TMC207; a Novel First-in-Class Antituberculosis Agent for the Treatment of Tuberculosis
Prof. Takeshi Iwatsubo
The University of Tokyo (JAPAN)
Abstract title: Alzheimer’s disease: from molecular pathology to disease-modifying therapy
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (USA)
Abstract title: Beta Cell G Protein-Coupled Receptors as Targets for the Treatment of Type 2 Diabetes
Dr. William Washburn
Bristol-Myers Squibb (USA)
Abstract title: Discovery of Dapagliflozin: A New Approach for Treatment of Type 2 Diabetes
Dr. Graeme Semple
Arena Pharmaceuticals, Inc (USA)
Abstract title: Discovery of Lorcaserin: A Selective 5-HT2C Agonist for Weight Management
National Institute of Health Sciences (JAPAN)
Abstract title: Risk Assessment and Management of Genotoxic Impurities in Pharmaceuticals
The University of Tokyo (JAPAN)
Abstract title: Chronic Inflammatory Response in Cardiovascular Remodeling and in Metabolic Syndrome
Prof. Joel P. Schneider
National Cancer Institute (USA)
Abstract title: Peptide-based Materials for Therapy
Prof. Jie-Oh Lee
Korea Advanced Institute of Science and Technology (KOREA)
Abstract title: Pattern Recognition by the Toll-like Receptor Family
Prof. Ichio Shimada
The University of Tokyo (JAPAN)
Abstract title: Dynamical Aspects of Membrane Proteins
Kyoto Pharmaceutical University (JAPAN)
Abstract title: Defying Difficult Diseases: Design and Synthesis of Transition-state Mimetic Protease Inhibitors
The University of Tokyo (JAPAN)
Abstract title: Block Copolymer Micelles and Vesicles as Nanocarriers for Gene and Drug Delivery
